focus -WSS

focus

author：leisure time 2025-09-10 08:40:45 - browse：47

the U.S. Medicare Handbook is photographed in Washington. — Pablo Martinez Monsivais/AP

Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program.

Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s, according to new federal Medicare Advantage enrollment data analyzed by STAT.

The data reinforce how America’s Medicare program continues to shift toward a more privatized version that has not saved any money for taxpayers, has been linked to inappropriate coding practices, and has restricted care for older and vulnerable patients. And even though the federal government made several changes to Medicare Advantage for 2024 — changes that were vehemently opposed by the health insurance industry — the program’s growth has not been stunted, nor did insurers dramatically slash their offerings.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Time to name cancers by genetics, not organ of origin, expert says

WSS

Apple Vision Pro: A first look at health apps on the new VR headset

Google and Epic fight stronger regulation of AI in health care

Cognito secures funding to test medical device for Alzheimer's

Medicare to cover more brain scans for Alzheimer’s patients

WHO calls for emergency meeting on new China virus, as cases spread

Cybersecurity threat forces Lurie Children's to take systems offline

explore

focus

leisure time

Medicare details structure of new drug price negotiation program

Medicare to cover more brain scans for Alzheimer’s patients

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Medicare details structure of new drug price negotiation program

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Activists slam private health insurers over coverage restrictions

Cognito secures funding to test medical device for Alzheimer's

Psychedelics group wrestles with new pharma identity

ARCH Venture Partners is raising $3 billion for a life sciences fund

focus

Woodcock on FDA’s accelerated approval and her next chapter

As digital health tech proliferates, a new institute aims to cut through hype

As digital health tech proliferates, a new institute aims to cut through hype

Commercial surrogacy can be ethical, despite pope’s claims

At Orexo, a ‘turning point’ for everything but digital health

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

leisure time

focus

hotspot

hotspot